US Stock MarketDetailed Quotes

ANAB AnaptysBio

Watchlist
  • 23.620
  • -0.480-1.99%
Trading Nov 26 09:59 ET
718.73MMarket Cap-3904P/E (TTM)

AnaptysBio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AnaptysBio Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.950M--
--2024/Q4-- / 10.105M--
--2024/Q330.017M / 8.166M--
--2024/Q210.971M / 22.757M--
--2024/Q17.179M / 3.971M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.950M--
--2024/Q4-- / 10.105M--
--2024/Q330.017M / 8.166M--
--2024/Q210.971M / 22.757M--
--2024/Q17.179M / 3.971M--

Unlock Free Earnings Estimates

AnaptysBio Earnings Reports

  • AnaptysBio | 10-Q: Q3 2024 Earnings Report

    Nov 5 16:22 ET

  • AnaptysBio | 8-K: Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update

    Nov 5 16:21 ET

  • AnaptysBio | 10-Q: Q2 2024 Earnings Report

    Aug 5 16:27 ET

  • AnaptysBio | 8-K: Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update

    Aug 5 16:23 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 19, 2024

    Strong Buy

    • Buy

      84.62%

    • Hold

      15.39%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data